7/20/2023 1:01:17 PM - Gapped down and it is slumping for a big loss today, abruptly retreating from its all-time high. Reported earnings +15% for the Jun '23 quarter versus the year-ago period. Prior quarters were not strong and steady above the +25% minimum earnings guideline (C criteria).
Slumped below its 50 and 200 DMA lines recently with damaging volume-driven losses, then its 200 DMA line recently acted as resistance when rebounding. Prior mid-day reports cautioned members - "Reported earnings +13% on +2% sales revenues for the Sep '15 quarter, and prior quarters were below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria)."
Slumped below its 50 and 200 DMA lines recently with damaging volume-driven losses. Reported earnings +13% on +2% sales revenues for the Sep '15 quarter, and prior quarters were below the +25% minimum earnings guideline (C criteria). Last noted with caution in the 4/23/15 mid-day report - "Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria)."
Rallying to new 52-week highs with a volume-driven gain today after finding support again at its 50 DMA line. Reported earnings +23% on +7% sales revenues for the Dec '14 quarter, below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria)."
Gapped down today after meeting resistance last week at its 50 DMA line, slumping below prior lows in the $131 area toward its 200 DMA line. Gains lacked volume-conviction since last noted with caution in then 11/07/14 mid-ay report - "Reported earnings +23% on +7% sales revenues for the Sep '14 quarter, below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria)."
Recently wedging into new high territory with gains lacking great volume conviction. Rebounded impressively after undercutting its 200 DMA line in October. Reported earnings +23% on +7% sales revenues for the Sep '14 quarter, below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria).
Rebounding to its 50 DMA line after undercutting its 200 DMA line with a spurt of volume-driven losses in recent weeks. Last noted with caution in the 7/28/14 mid-day report - "Reported earnings +20% on +8% sales revenues for the Jun '14 quarter, below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria)."
Perched near its 52-week high today, stubbornly holding its ground following a considerable gap up and volume-driven gain on 7/17/14. Found support its 50 DMA line recently. Reported earnings +20% on +8% sales revenues for the Jun '14 quarter, below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria).
Perched at its 52-week high today following a considerable gap up and volume-driven gain on the prior session. Found support its 50 DMA line recently. Reported earnings +20% on +8% sales revenues for the Jun '14 quarter, below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-8% range, not indicative of a hot new product or service (N criteria).
Consolidating near its 52-week high and above its 50 DMA line. Reported earnings +16% on +7% sales revenues for the Mar '14 quarter, below the +25% minimum earnings guideline (C criteria). Sales revenues increases have only been in the +3-7% range, not indicative of a hot new product or service (N criteria).
Gapped up today and hit a new 52-week high. Reported earnings +9% on +3% sales revenues for the Sep '12 quarter, its 2nd consecutive quarterly comparison below the +25% minimum earnings guideline (C criteria) while sales revenues increases have only been in the +3-7% range. A downturn in FY '09 earnings (A criteria) history is also a fundamental concern.
Reported earnings +14% on +3% sales revenues for the Jun '12 quarter. Rallied to new 52-week highs with a spurt of volume-driven gains since last noted in the 6/26/12 when slumping below its 50 DMA line - "Recent quarterly comparisons show earnings above the +25% guideline satisfying the C criteria, however sales revenues increases have only been in the +7-14% range. Its up and down annual earnings (A criteria) history was also a concern when last noted in the 7/01/11 mid-day report, and it subsequently went through a deep consolidation below its 200 DMA line before rebounding impressively."
Slumping below its 50 DMA line this week after recently wedging to a new 52-week high with gains lacking great volume conviction. Recent quarterly comparisons show earnings above the +25% guideline satisfying the C criteria, however sales revenues increases have only been in the +7-14% range. Its up and down annual earnings (A criteria) history was also a concern when last noted in the 7/01/11 mid-day report, and it subsequently went through a deep consolidation below its 200 DMA line before rebounding impressively.
Inching to a new 52-week high today, posting its 11th gain in the span of 12 sessions. It found support near its 200 DMA line and prior chart lows in the $55 area earlier in June while enduring distributional pressure. Recent quarterly comparisons show improving sales and earnings above the +25% guideline for 3 consecutive quarters, but sales revenues increases have only been in the +14-15% range and its up and down annual earnings (A criteria) history is a concern.
Hit a new 52-week high today. It found support near its 200 DMA line and prior chart lows in the $55 area earlier in June while enduring distributional pressure. Recent quarterly comparisons show improving sales and earnings above the +25% guideline for 3 consecutive quarters, but sales revenues increases have only been in the +14-15% range and its up and down annual earnings (A criteria) history is a concern.
Consolidating near its 52-week high reached last week. Recent quarters showed improving sales and earnings, but negative prior comparisons and its up and down annual earnings (A criteria) history are concerns.
Trading at a new multi year high however sales and group action below guidelines.
Trading at a new multi year high however sales and group action below guidelines.